Development and validation of a high‐performance liquid chromatography method for determination of lisinopril in human plasma by magnetic solid‐phase extraction and pre‐column derivatization
- 16 November 2017
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 32 (3)
Abstract
A sensitive, reliable and simple HPLC method was developed for the determination of lisinopril in human plasma. The method consists of extraction and clean‐up steps based on magnetic solid‐phase extraction and pre‐column derivatization with a fluorescent reagent. The mobile phase consisted of a mixture of methanol–sodium dihydrogen phosphate (pH 3.0; 0.005 m; 75:25, v/v). The flow rate was set at 0.7 mL/min. Fluorescence detection was performed at 470nm excitation and 530nm emission wavelengths. Total chromatography run time was 5 min. The average extraction recovery of lisinopril and fluvoxamine (internal standard) was ≥82.8%. The limits of detection and quantification were determined as 1 and 3 ng/mL respectively. The method exhibited a linear calibration line over the concentration range of 3–1000 ng/mL with coefficient of determination (r2) of ≥0.98. The within‐run and between‐run precisions were satisfactory with values of CV of 1.8–12.8% (accuracy from 99.2 to 94.7%) and 2.4–13.7% (accuracy from 99.5 to 92.2%), respectively. These developments led to considerable improvement in method sensitivity and reliability. The method was validated according to the US Food and Drug Administration guidelines. Therefore, it can be considered as a suitable method for determination of lisinopril in plasma samples.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (93-03-46-27509)
This publication has 35 references indexed in Scilit:
- Development and Validation of RP-HPLC Method for the Estimation of Lisinopril in Tablet Dosage FormAnalytical Chemistry Letters, 2012
- Quantitative determination of lisinopril in human plasma by high performance liquid chromatography–tandem mass spectrometry and its application in a pharmacokinetic studyBiomedical Chromatography, 2011
- Amino acids analysis using a monolithic silica column after derivatization with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F)Journal of Chromatography B, 2011
- Evolution of dispersive liquid–liquid microextraction methodJournal of Chromatography A, 2010
- Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugsSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2007
- Rapid quantification of lisinopril in human plasma by liquid chromatography/tandem mass spectrometryBiomedical Chromatography, 2007
- Bioequivalence evaluation of two brands of lisinopril tablets (Lisotec and Zestril) in healthy human volunteersBiopharmaceutics & Drug Disposition, 2005
- Determination of fluvoxamine in rat plasma by HPLC with pre‐column derivatization and fluorescence detection using 4‐fluoro‐7‐nitro‐2,1,3‐benzoxadiazoleBiomedical Chromatography, 2005
- An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detectionJournal of Chromatography B, 2004
- Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serumJournal of Pharmaceutical and Biomedical Analysis, 1996